Author:
Purim Ofer,Beny Alexander,Inbar Moshe,Shulman Katerina,Brenner Baruch,Dudnik Elizabeth,Bokstein Felix,Temper Mark,Limon Dror,Matceyevsky Diana,Sarid David,Segal Amiel,Semenisty Valeriya,Brenner Ronen,Peretz Tamar,Idelevich Efraim,Pelles-Avraham Sharon,Meirovitz Amichay,Figer Arie,Russell Kenneth,Voss Andreas,Dvir Addie,Soussan-Gutman Lior,Hubert Ayala
Funder
Caris Life Sciences
Teva Pharmaceutical Industries
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference33 articles.
1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx . Accessed 30 July 2016.
2. Bilici A. Treatment options in patients with metastatic gastric cancer: current status and future perspectives. World J Gastroenterol. 2014;20:3905–15.
3. Gunturu KS, Woo Y, Beaubier N, Remotti HE, Saif MW. Gastric cancer and trastuzumab: first biologic therapy in gastric cancer. Ther Adv Med Oncol. 2013;5:143–51.
4. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687–97.
5. Kim HS, Kim HJ, Kim SY, Kim TY, Lee KW, Baek SK, et al. Second-line chemotherapy versus supportive cancer treatment in advanced gastric cancer: a meta-analysis. Ann Oncol. 2013;24:2850–4.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献